JOSEPH HEIMBAUER: Open Payments
NPI 1881900363 · GARDEN CITY, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$324 in 13 payments from 8 companies in 2025. Trend: 2023 $943 · 2024 $608 · 2025 $324
Food & beverage: $289Education: $35
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 3 | $84 |
| TOLMAR, INC. | 2 | $50 |
| Sumitomo Pharma America, Inc. | 2 | $46 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $39 |
| AstraZeneca Pharmaceuticals LP | 1 | $35 |
| PROGENICS PHARMACEUTICALS, INC. | 1 | $29 |
| Myriad Genetic Laboratories, Inc. | 1 | $24 |
| Laborie Medical Technologies Corp. | 1 | $17 |
Products named: ERLEADA, ELIGARD, ORGOVYX, Nubeqa, IMFINZI, PYLARIFY, PROLARIS.
Industry payments across NY — which companies pay providers there.
